Reuters logo
BRIEF-Can-Fite's phase III acrobat trial in rheumatoid arthritis approved by institutional review board
April 25, 2017 / 11:41 AM / 8 months ago

BRIEF-Can-Fite's phase III acrobat trial in rheumatoid arthritis approved by institutional review board

April 25 (Reuters) - Can Fite Biopharma Ltd

* Can-Fite’s phase III acrobat trial in rheumatoid arthritis approved by institutional review board

* Can-Fite to conduct investigator meeting in Europe with approximately 100 doctors from participating clinical sites Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below